- Death rate drops among Americans with diabetes -CDC
ATLANTA (Reuters) - A 40 percent decline in the death rate of diabetic American adults from heart disease and strokes is a sign that patients are taking better care of themselves and receiving improved treatment, according to a government study released on Tuesday. While the drop in death rates from cardiovascular disease was the most dramatic, overall death rates among diabetic adults dropped 23 percent from 1997 to 2006, according to the study by researchers at the U.S. Centers for Disease Control and Prevention and the National Institutes of Health. ...
- Colonoscopy May Detect Curable Cancer in Elderly: Study
TUESDAY, May 22 (HealthDay News) -- Colonoscopies helped doctors detect a high rate of curable cancer in elderly people who had the screening for the first time, a new study indicates.
- Asthma Meds May Be Linked to Irregular Heartbeat
TUESDAY, May 22 (HealthDay News) -- New research suggests that young asthma patients who use drugs known as inhaled anticholinergics -- such as ipratropium [Atrovent] -- could be more likely than others to suffer from potentially dangerous irregular heartbeat.
- Studies See Advances in Detecting, Treating Pancreatic Cancer
TUESDAY, May 22 (HealthDay News) -- Two preliminary studies suggest that some headway is being made in both the detection and treatment of pancreatic cancer.
- U.S. Sees Drop in Deaths Linked to Diabetes
TUESDAY, May 22 (HealthDay News) -- Healthier lifestyles and better disease management led to a sharp drop in death rates for Americans with diabetes between 1997 and 2006, especially deaths caused by heart disease and stroke, a new federal government report shows.
- Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk
TUESDAY, May 22 (HealthDay News) -- Certain gene variants linked to prostate cancer may make men more susceptible to lower urinary tract symptoms, according to a new study. On the other hand, a different gene variant might protect against those symptoms, the study found.
- Do Bald Men Face Higher Risk of Prostate Cancer?
TUESDAY, May 22 (HealthDay News) -- Got hair? If you don't, you might have a higher risk of prostate cancer, a preliminary study suggests.
- U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer
MONDAY, May 21 (HealthDay News) -- In a highly anticipated move sure to unleash heated debate, a prominent U.S. government advisory panel is recommending that men of all ages no longer be screened for prostate cancer by undergoing the prostate-specific antigen (PSA) blood test.
- Scripps: Cancer could rise if PSA screenings eliminated
In a controversial decision, the U.S. Preventive Services Task Force is recommending that healthy men not undergo the prostate-specific antigen (PSA) test. That could lead to an increase in cancer, says Dr. Carl Rossi Jr., a Scripps prostate cancer expert.
- Third of malaria drugs in SE Asia are fake
More than a third of malaria drugs examined by scientists in Southeast Asia were fake, and a similar proportion analysed in Africa were below standard, doctors warned on Tuesday.
- Folic acid tied to lower child cancer risks
NEW YORK (Reuters Health) - Rates of two rare childhood cancers declined after the U.S. began requiring grain products to be fortified with the B vitamin folic acid, a new study finds. Reported in the journal Pediatrics, the study does not prove that folic acid deserves the credit. But researchers say the findings at least offer reassurance that folic-acid fortification has not led to an increase in children's cancers -- which has been a theoretical concern. "The good news is that there doesn't seem to have been an increased risk of childhood cancer," said lead researcher Amy M. ...
- Flesh-Eating Disease Lands Man Down Hall From Aimee Copeland
A Georgia landscaper is battling flesh-eating disease at the same Augusta hospital as Aimee Copeland, the 24-year-old student who lost her leg to the deadly infection.
- FDA staff shoots down Pfizer rare disease drug
WASHINGTON (Reuters) - Drug reviewers on Tuesday recommended rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a rare neurodegenerative disease. The U.S. Food and Drug Administration staff reviewed the pill, tafamidis, ahead of an advisory panel of outside experts, which on Thursday will vote on whether to recommend it for approval. The FDA will make a final decision later, taking into account the panel's recommendation. ...
- Study: Fake malaria drugs common in Asia, Africa
More than a third of the malaria-fighting drugs tested over the past decade in Southeast Asia and sub-Saharan Africa were either fake or bad quality, seriously undermining efforts to fight the disease, a study said Tuesday.
- Eli Lilly's diabetes drug meets mid-stage trial goal
(Reuters) - Drugmaker Eli Lilly and Co's experimental drug to treat type 2 diabetes met the main goal of a mid-stage trial to test its effect on blood pressure and heart rate. The results of the study showed that the effect of Lilly's drug, dulaglutide, on systolic blood pressure was comparable to that of a placebo. Makers of type 2 diabetes pills are required by the U.S. health regulator to prove that the drugs do not increase the risk of heart attacks or other heart problems. ...
- Flesh-Eating Disease Lands Man in Same Hospital as Aimee Copeland
Bobby Vaughn, 32, Is Battling a Similar Infection in the Same Augusta Hospital
- Obese More Likely to Be Diagnosed With Advanced Thyroid Cancer
MONDAY, May 21 (HealthDay News) -- Obese patients are more likely than other patients to have advanced, aggressive forms of papillary thyroid cancer when they're diagnosed with the disease, a new study has found.
- Dieting May Lower Hormone Levels Tied to Breast Cancer
MONDAY, May 21 (HealthDay News) -- New research suggests that weight loss through exercise and dieting helps overweight women lower the levels of certain hormones in their blood, potentially raising the odds that they'll avoid developing breast cancer.
- Could Compound in Artificial Sweeteners Worsen Crohn's Disease?
MONDAY, May 21 (HealthDay News) -- The food additive maltodextrin, commonly used in some artificial sweeteners, may worsen Crohn's disease by encouraging the growth of E. coli bacteria in the small intestine, a new study suggests.
- Severe Gum Disease, Impotence May Be Linked
MONDAY, May 21 (HealthDay News) -- Men with severe gum disease, known as periodontitis, are at greater risk for impotence, according to a new study that finds young men and the elderly at particular risk.
- Screening for Lung Cancer Might Benefit Those at Highest Risk
SUNDAY, May 20 (HealthDay News) -- Using low-dose CT scans to screen for lung cancer might save the lives of patients at the greatest risk for the disease, a new analysis suggests.
- Breathing Smog While Pregnant May Worsen Asthma in Offspring
SUNDAY, May 20 (HealthDay News) -- Exposure to air pollution while in the womb might harm the lung-function development of children with asthma, a new study finds.
- Sleep Apnea Linked to Higher Cancer Death Risk
SUNDAY, May 20 (HealthDay News) -- Sleep apnea has already been linked to a host of adverse health problems, such as high blood pressure and heart disease. Now, new research suggests that in people who already have cancer, the sleep disorder may raise their risk of dying from cancer.
- Fake malaria drugs litter Southeast Asia, Africa
A study says more than a third of malaria-fighting drugs tested over the past decade in Southeast Asia and sub-Saharan Africa were either fake or bad quality.
- U.S. task force: End routine prostate cancer screening
NEW YORK (Reuters) - A task force advising the U.S. government on Monday recommended against routine use of the prostate-cancer screening test called PSA, or prostate specific antigen, for lack of a discernible health benefit. Like a draft proposal last October, the U.S. Preventive Services Task Force gave PSA screening a D, for "don't recommend" in healthy men. The reaction was fast and furious. Screening advocates warned that the recommendation will cost lives, but critics of PSA testing said thousands of men will be spared impotence and incontinence as a result of needless cancer treatment. ...